The implementing experience of pharmaceutical risk-sharing agreements in Australia, New Zealand, Taiwan area and its implication for mainland China
10.3969/j.issn.1674-2982.2017.02.004
- VernacularTitle:药品风险分担协议对中国大陆的启示——以澳大利亚、新西兰、中国台湾为例
- Author:
Penglei CUI
;
Shiyong LI
;
Feng CHANG
;
Yun LU
- Keywords:
Risk-sharing agreements;
Uncertainly;
Cost-effectiveness
- From:
Chinese Journal of Health Policy
2017;10(2):21-26
- CountryChina
- Language:Chinese
-
Abstract:
With the rapid development of healthcare technologies, the improvement of patient health expecta-tions, and the increasing of the government or insurer's financial budget pressure, risk-sharing agreements has be-come the focus of the governments or insurer concerned. This article systematically analyzed Australia, New Zealand, Taiwan risk-sharing agreements from five aspects, including the operation main, scope, classification, application processes and the implementation effects. According to the results of the analysis, we suggests that China should im-prove risk-sharing agreements theoretical basis, diversify risk-sharing agreements models, establish risk-sharing a-greements standardization process and so on.
